Tomsick and Abbottsmith Receive Kaplan Award
Tom Tomsick, MD, and Charles Abbottsmith, MD, have won the Samuel Kaplan, MD, Visionary Award for their contributions to cardiovascular medicine. Dr. Tomsick, professor and director of neuroradiology, and Dr. Abbottsmith, adjunct professor of cardiology, received their awards Feb. 26 at the American Heart Association's 11th Annual Heart Ball. Dr. Tomsick has been a member of the College of Medicine faculty since 1983 and is a world-renowned interventional neuroradiologist. He pioneered new treatments for bleeding strokes and also helped develop techniques that deliver clot-busting drugs directly to the blockage in the brain. Dr. Abbottsmith, director of cardiology at the Christ Hospital, received the award for his innovations in cardiovascular research over three decades. The award honors those who continue the tradition of excellence in cardiovascular science exemplified by Dr. Kaplan, founder and former director of cardiology at Cincinnati Children's and former professor of pediatric cardiology at UC. With Leland Clark, PhD, Dr. Kaplan pioneered the use of the heart-lung machine, and also led the development of cardiac catheterization and echocardiology.
International Research Team Says Blood Clotting Agent Can Save Stroke Patients
UC scientists working with researchers in Australia, Denmark and Germany have shown that early treatment with a recombinant blood clotting factor can save the lives of patients with a form of stroke known as intracerebral (brain) hemorrhage. Early treatment with recombinant activated factor VII, marketed as NovoSeven, can also improve the likelihood that brain hemorrhage patients will be able to speak, walk and eat normally again. The international team, including Joseph Broderick, MD, head of UC's neurology department, reported the results of a study of 400 brain hemorrhage patients in the Feb. 24 issue of the New England Journal of Medicine. These latest NovoSeven studies are based in part on work done by UC College of Medicine researchers during the late 1980s and 1990s. UC scientists were first to demonstrate conclusively that bleeding continues for several hours after onset of a brain hemorrhage and is a major reason for the rapid deterioration in these patients.
Support the IvaDean Scholarship Fund
Don't forget to come out and support the IvaDean Medical Student Scholarship Fund Friday, March 11 at 7 p.m. Emceed by Bruce Giffin, PhD, the IvaDean Scholarship Benefit Concert will showcase the talent of COM students and colleagues. Tickets are $5 for students and $20 for the general public. Scheduled performances by the rock group The Source, led by Michael Borack, PsyD, and contemporary rock sounds of The Kocher Maneuver, featuring Jeffrey Matthews, MD, and Shahab Akhter, MD, are sure to be crowd pleasers. For more information, e-mail firstname.lastname@example.org.
More Training Needed to Care for Growing Geriatric Population
Elizabeth Bragg, PhD, of UC's Institute for the Study of Health, and Gregg Warshaw, MD, professor of geriatric medicine and family medicine at UC, co-authored an article in the March 2005 issue of Academic Medicine that says older adults are making more visits to nonprimary-care specialists and suggests faculty development and curriculum changes be made to better prepare future physicians to handle this growing patient base. For more information on their research to date, visit www.adgapstudy.uc.edu.
Brain and Stroke Researchers Meet at UC March 10-13
Some of the nation's leading scientists and physicians specializing in stroke and neurological diseases will meet at three scientific events at the Kingsgate Marriott to share the latest research and treatment approaches. UC is hosting the March 1011 annual meeting of the six centers involved in the network for Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS). UC was the first to join the network, which is funded by the National Institutes of Health. On March 11 and 12, the Ninth Cincinnati Neurofest will discuss new therapies and improved patient care for epilepsy, drug abuse, neurodegenerative disorders such as Parkinson's disease, and the latest findings on brain imaging, gene research and treatments for brain disease. The Third Cincinnati Translational Neuroscience Symposium will meet at the Kingsgate March 12.
Sickle Cell Annual Meeting
The Cincinnati Comprehensive Sickle Cell Center will host the 28th Annual Meeting of the National Sickle Cell Disease Program in April. This NIH-sponsored conference brings together basic and clinical scientists, clinicians, nurses, social workers, counselors, psychologists and others interested in sickle cell disease to report on the latest research and treatment. For registration information, contact Julia Robertson at email@example.com or 513-636-2804. CMEs for medicine, nursing and social work will be available.
New Cancer Symptom Clinic Opens
A new interdisciplinary cancer symptom management clinic is open and now accepting referrals from Barrett Cancer Center physicians for management of pain, anemia/fatigue or nutrition concerns related to cancer diagnosis or cancer treatment. Referral forms are available at the Barrett Cancer Center Clinic areas or by calling 584-0223.
Queen City 101
Keleket in Covington was the world's largest manufacturer of X-ray equipment throughout the early 1990s. During World War I, Keleket supplied virtually all of the X-ray equipment used at American base hospitals in Europe.